Showing 661 - 680 results of 1,763 for search '(( i dna decrease ) OR ( 10 ((peter decrease) OR (((mean decrease) OR (a decrease)))) ))*', query time: 0.20s Refine Results
  1. 661
  2. 662

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673

    Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents by Ayoub, Abeer J.

    Published 2023
    “…Inhibition of the expression of the antiapoptotic protein Bcl-2 and concentration-dependent cleavage of PARP-1, as well as DNA fragmentation by approximately 80%, were described. …”
    Get full text
    Get full text
  14. 674
  15. 675

    The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population. by Bader, Loulia

    Published 2020
    “…Carriers of at least one CYP2C9 decreased function allele (*2 or *3) required lower median (IQR) warfarin doses compared to noncarriers [24.5 (14.5) mg/week vs. 35 (21) mg/week, p < 0.001]. …”
    Get full text
    Get full text
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680